Recent News in Stem Cell Research.

We have archived current news and research breakthroughs related to our field of stem cell research.

1.24.11 - Researchers Eliminate Major Roadblock In Regenerative Medicine

UCLA Stem cell biologists and engineers have identified an optimal concentration of small-molecule inhibitors to ensure the long-term quality and maintenance of human embryonic stem (HES) cells in feeder-free and serum-free conditions. This research discovery signals a breakthrough in regenerative medicine's transition from concept to the clinic.

1.22.11 - Research Pinpoints Moment When Stem Cell Progeny Lose "Stemness"

In a study of hair follicle stem cells, Rockefeller University scientists have defined the point at which the stem cells discard their trademark versatility, or "stemness." Hair follicle stem cells are usually inactive, but when activated they rapidly reproduce and lose their "stemness" to make new hairs. The Rockefeller University researchers broke down this cycle, eventually finding the point at which activated stem cells become irreversibly committed to specializing in the cells needed to grow hair.

1.19.11 - Math Model Calculates Speed Of Stem Cell Replication

Researchers have devised a series of mathematical steps that allow one to assess how rapidly stem cells and their malignant, stemlike alter egos reproduce. In the past, the task of counting stem cells and their cancer-causing cousins was accomplished (not very accurately) with powerful microscopes, high-throughput screening systems and protein assays. According to associate professor of neurosurgery at UF's McKnight Brain Institute, Brian Reynolds, Ph.D., "math is going to be the new microscope of the 21st century because it is going to allow us to see things in biology that we cannot see any other way."

1.13.11 - Study Data Show Potential Of Company's Stem Cell Therapy For Spinal Injury

Data from Case Western Reserve University School of Medicine and stem cell company Athersys' rat studies show strong evidence of therapeutic benefit of stem cell-based therapy for spinal cord injury. In the study, Multipotent Adult Progenitor Cells (MAPC) administered to subjects following spinal cord injury prevented the retraction of neurons (known as "axonal dieback"), reduced inflammation in the region of injury, and also promoted the regrowth of neurons.